Home Cart Sign in  
Chemical Structure| 2158197-70-5 Chemical Structure| 2158197-70-5

Structure of HS-1371
CAS No.: 2158197-70-5

Chemical Structure| 2158197-70-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

HS1371 is an ATP-competitive and novel kinase inhibitor of RIP3-mediated necroptosis which can directly bind to RIP3.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of HS-1371

CAS No. :2158197-70-5
Formula : C24H24N4O
M.W : 384.47
SMILES Code : CC1=CC=C(OC2=CC=NC3=CC(C4=CN(C5CCNCC5)N=C4)=CC=C23)C=C1
MDL No. :MFCD31813738
InChI Key :VPVLPCIBKVWFDT-UHFFFAOYSA-N
Pubchem ID :134817449

Safety of HS-1371

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of HS-1371

pyroptosis

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
MEF cells 5 μM To test the inhibitory effect of HS-1371 on TNF plus CHX and zVAD-induced necroptosis in mouse embryonic fibroblast MEF cells. Results showed that HS-1371 effectively inhibited MLKL phosphorylation and cell death. Exp Mol Med. 2018 Sep 20;50(9):1-15
L929 cells 5 μM To test the inhibitory effect of HS-1371 on TNF plus zVAD-induced necroptosis in mouse fibrosarcoma L929 cells. Results showed that HS-1371 effectively inhibited necroptosis. Exp Mol Med. 2018 Sep 20;50(9):1-15
HT-29 cells 10 μM 9 hours To test the inhibitory effect of HS-1371 on RIP3 S227 auto-phosphorylation. Results showed that HS-1371 effectively inhibited RIP3 S227 auto-phosphorylation. Exp Mol Med. 2018 Sep 20;50(9):1-15
H2009 cells 0-10 μM 6 hours To test the inhibitory effect of HS-1371 on TSZ-induced necroptosis in H2009 cells with ectopic RIP3 expression. Results showed that HS-1371 effectively inhibited TSZ-induced necroptosis. Exp Mol Med. 2018 Sep 20;50(9):1-15
HeLa cells 0-10 μM 6 hours To test the inhibitory effect of HS-1371 on RIP3 phosphorylation in HeLa cells with ectopic RIP3 expression. Results showed that HS-1371 dose-dependently inhibited RIP3 phosphorylation. Exp Mol Med. 2018 Sep 20;50(9):1-15
mouse intestinal organoids (MI organoids) 10 nM 48 hours To evaluate the inhibitory effect of HS-1371 on toceranib-induced necrotic cell death. Results showed that HS-1371 significantly reduced the cell death rate in MI organoids and suppressed the expression of necrosis-related genes RIPK3 and Mlkl. Sci Rep. 2025 Jan 2;15(1):39

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice B16 melanoma model In vitro treatment 2 μM Single treatment Evaluate the effect of HS-1371 on TNFα/IFNγ-induced cell death Nature. 2023 Mar;615(7950):158-167

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.60mL

0.52mL

0.26mL

13.00mL

2.60mL

1.30mL

26.01mL

5.20mL

2.60mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories